文献速递临床试验与 GCP

高压氧治疗退伍军人和服役人员创伤性脑损伤的疗效:一项盲法三阶段组序贯随机对照试验的研究方案

Efficacy of hyperbaric oxygen treatment in veterans and service members with traumatic brain injury-a study protocol for a blinded three-stage group sequential randomized controlled trial.
PubMed 文献 · Trials · 2026-03-25

本研究为单中心盲法组序贯优效性随机对照试验,纳入伤后一年以上、神经行为症状持续(NSI≥22)的轻中度创伤性脑损伤退伍军人及服役人员,比较2.0 ATA高压氧与1.0 ATA常压氧安慰组的疗效。主要结局为干预后NSI评分,计划入组420例,预计脱落率20%。

要点

  • 高压氧组为2.0 ATA、约60分钟,安慰组为1.0 ATA、21%氧浓度。
  • 主要结局为干预后神经行为症状量表(NSI)评分。
  • 次要结局包括达到NSI下降所需高压氧次数及PTSD症状(PCL-5)。

核心结论

  • 该研究将确定2.0 ATA高压氧对轻中度TBI后慢性神经行为症状的疗效。

研究设计与样本

  • 单中心盲法三阶段组序贯优效性随机对照试验。
  • 计划入组420例伤后一年以上、NSI≥22的轻中度TBI退伍军人及服役人员,预计脱落率20%。

关键数值与推荐

  • 主要结局为干预后NSI评分。
  • 次要结局为达到NSI下降所需高压氧次数及PCL-5评估的PTSD症状。
  • 高压氧组:2.0 ATA医学级氧气,Sechrist 3600H/HR单人舱,约60分钟。
  • 安慰组:1.0 ATA常压、21%氧浓度,约60分钟。
  • 纳入标准:伤后一年以上持续神经行为症状,NSI≥22。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Traumatic brain injury (TBI) is common amongst Veterans and Military Service Members (V/SM), with 510,000 diagnosed with a TBI between 2000 and 2024, of which 82% were mild and 12% moderate. Hyperbaric oxygen therapy (HBOT) is considered a potential intervention for the management of mild/moderate TBI. However, the results from previous randomized controlled trials (RCTs) assessing the efficacy of HBOT for managing mild/moderate TBI are inconclusive due to several reasons, including lack of a priori power analyses, design considerations, and inappropriate comparators. The primary objective of this study is to assess the efficacy of HBOT compared to placebo/sham in reducing chronic neurobehavioral symptoms in participants with chronic mild to moderate TBI. METHODS: This is a single-center blinded group sequential superiority randomized controlled trial (RCT). All consecutive United States (USA) V/SM with a history of mild or moderate TBI with persistent neurobehavioral symptoms (≥ 22 on the Neurobehavioral Symptom Inventory) at a year or more post-injury will be eligible for inclusion. HBOT medical grade oxygen pressurized to 2.0 Atmospheres Absolute (ATA) with Sechrist 3600H/HR monoplace hyperbaric chambers will be compared to a sham group of 1.0 ATA (normobaric) with oxygen delivered at 21% (normal oxygen concentration in room air) for approximately 60 min. The primary outcome is the post-intervention Neurobehavioral Symptom Inventory (NSI) score. Secondary outcomes are the number of HBOT dives needed to achieve a reduction in NSI score and to assess the impact of HBOT on post-traumatic stress disorder (PTSD) symptoms using the PTSD Checklist for DSM-5 (PCL-5). The study aims to enroll 420 subjects with an expected dropout rate of 20%. DISCUSSION: The study will determine the efficacy of HBOT at 2.0 ATA in reducing long-term neurobehavioral symptoms in V/SM with histories of mild to moderate TBI. This information will assist participants, providers, and policy members in managing chronic neurobehavioral symptoms after TBI. TRIAL REGISTRATION: NCT06581003 (registered on 8/28/2024) https://clinicaltrials.gov/study/NCT06581003?term=NCT06581003&rank=1.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Neumann D, Kumar A, Van Loveren H, et al. Efficacy of hyperbaric oxygen treatment in veterans and service members with traumatic brain injury-a study protocol for a blinded three-stage group sequential randomized controlled trial. Trials. 2026. PMID: 41882764. doi:10.1186/s13063-026-09645-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。